Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 74

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 74
---
 owned
and were entitled to vote shares of Enfusion Common Stock and Enfusion Class B Common Stock, or approximately % of the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock.
Enfusion currently expects that these directors and executive officers will vote their shares in favor of the Merger Agreement Proposal and the Adjournment Proposal, although none of the directors and executive officers, other than Oleg Movchan with
respect to the Merger Agreement Proposal and the Adjournment Proposal, are obligated to do so.

Mr. Movchan is Enfusion’s Chief
Executive Officer and a member of the Enfusion Board. As noted above, pursuant to the Support Agreements, the Significant Stockholders agreed to vote all of the shares of Enfusion Securities held by them (representing in the aggregate approximately
% of the total outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock as of the record date) in favor of the Merger Agreement Proposal. See the section titled “The Support Agreements.”

Quorum and Broker Non-Votes

In order to conduct any business at the Special Meeting, a quorum must be present virtually or represented by proxy. Holders of shares
representing at least a majority of the total outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock on the record date entitled to vote at the Special Meeting, represented virtually or by proxy, constitute a quorum.
Enfusion Stockholders choosing to abstain from voting will be treated as present for purposes of determining whether a quorum is present, but will not be counted as votes cast “FOR” any matter.

Banks, brokerage firms and other nominees who hold shares in “street name” for the accounts of their clients may vote such shares
either as directed by their clients or in their own discretion on “routine” matters. When a broker does not receive instructions from a beneficial owner on how to vote shares with respect to a
“non-routine” matter, a broker “non-vote” occurs. Because neither the Merger Agreement Proposal nor the Adjournment Proposal will be considered
“routine,” broker “non-votes” will not be treated as present for purposes of determining whether a quorum is present and will not be counted as votes cast “FOR” any matter. A
broker non-vote, if any, will have the same effect as a vote “AGAINST” the Merger Agreement Proposal and will not have any effect on the Adjournment Proposal (assuming a quorum is